MyAbilities Technologies, a company involved in smart health technology and workplace safety, has launched what is claimed to be the world's first online Digital Job Analysis database, JobXweb.com, it was reported yesterday.
The free database offers users access to more than 50,000 job titles, each with unique industry Digital Job Profiles including comprehensive analysis of the psychosocial, cognitive and physical demands in addition to a comprehensive job description. Each Digital Job Profile includes the essential demands of that job, whether they are physical, cognitive or psychosocial. Digital Job Profiles are shared with various stakeholders to support decisions leveraging the exact same set of data in a standardised, visual way to understand all the demands of the job.
Dr Michael Sonne, vice president, innovations and research at MyAbilities Technologies, said, 'Organisations can quickly search through a simple and free database to conduct a thorough review of the demands of thousands of jobs across all industries. We believe JobXweb.com is the first of its kind to offer easy access to a standardised analysis of thousands of jobs, and to present the information in a clear, shareable way.'
Mirecule expands collaboration with Sanofi to advance FSHD therapy
Sanofi's venglustat receives FDA Breakthrough Therapy designation for type 3 Gaucher disease
Alebund Pharmaceuticals signs licensing and equity agreements with R1 Therapeutics
Apertura Gene Therapy agrees manufacturing collaboration with Viralgen
Humacyte submits Israel MAA for Symvess arterial trauma repair
Sentynl Therapeutics and PRG S&T enter licensing agreement for potential HGPS treatment
NeuroSense Therapeutics reports Phase 2b trial results of PrimeC in ALS
Imfinzi approved in EU for perioperative treatment of early gastric and gastroesophageal cancers
LynxKite Technologies expands Biophytis collaboration
BioDlink named 'Emerging CDMO of the Year' at Asia-Pacific Biopharma Excellence Awards
Vimgreen Pharmaceuticals receives IND clearance for VG081821 in China
Emerald Clinical Trials honoured with 2026 Asia Pacific Biopharma Excellence Award